Papers
Research literature with structured metadata.
Trials
Registered studies by status, phase, and compound.
Topics
Indications and themes psychedelics are researched for.
Compounds
Evidence across molecules with rich data.
Countries
Regulation, access, and research activity by region.
Stakeholders
Organizations shaping the space across research, policy, and funding.
People
Investigators, clinicians, and authors with mapped output.
Courses
Training programs and certifications across modalities.
Events
Conferences, workshops, and convenings by date and focus.
Research recaps
Monthly evidence summaries with key takeaways.
Map of research
Landscape view of trials, compounds, and outcomes.
Newsletter
Weekly or daily updates on trials, publications, analysis, and more.
Research Groups
Worldwide map of psychedelic research centres by region.
Research Network
Interactive co-authorship map of psychedelic researchers.
Top papers
Find needles in the haystack of psychedelic research per topic.
A survey of 1,000 American Psychiatric Association members (32% response) found most psychiatrists view classic hallucinogens as potentially hazardous and appropriately illegal for recreational use, but a substantial minority—especially male, trainee and younger psychiatrists—reported greater optimism about their therapeutic potential.
This double-blind cross-over study (n=12) showed that LSD (200 μg, 2 sessions) in combination with psychotherapy was safe to use and trended towards a positive effect on end-of-life anxiety.
This review article (1995) looks back at the pre-renaissance studies on psychedelics.
This literature review (1984) examines the basic pharmacology and potential adverse effects of synthetic psychedelics, primarily LSD. It concludes that while acute adverse reactions occur, there is little evidence for organic brain damage or permanent negative changes in personality among users.
This early review (1960) details the prevalence of some possible side effects and complications of LSD from the literature. The discussion includes prolonged psychotic symptoms, (attempted) suicides, and others.
This early report (1963) analyzes questionnaire responses of participants about their experiences under the influence of psilocybin in a supportive environment and found that group size and atmosphere (setting) were important determinants of the quality of the experience.